Ofeva

Looking for Ofev follow-up, Boehringer picks up Bridge Biotherapeutics' IPF med for $50M
Fierce Biotech
Thu, 07/18/19 - 11:38 am
Boehringer Ingelheim
Bridge Biotherapeutics
Ofeva
IPF
BBT-877